HomeUpdatesBig Pharma › All

All

Blog Post
11/7/2016
By Jamie Court
Bernie Sanders came to Los Angeles’s Pershing Square today to tell Californians not to be deceived by the $130 million drug companies have spent against Prop 61’s controls on California drug prices. “Drug companies are spending over $130 million to defeat this initiative and to make certain the people of California and the...
News Release
11/2/2016
CONTACT Jamie Court & Cody Rosenfield
Santa Monica, CA -- In the final days of the election campaign, and as the pharmaceutical industry expands its spending against Prop 61 to a record $126 million, Wall Street analysts’ private research on Proposition 61 finds that drug companies will take modest profit hits if it passes but that the industry will remain relatively unscathed....
News Release
10/20/2016
CONTACT Carmen Balber & Jamie Court
Santa Monica, CA -- Drug companies poured $22 million more into their campaign to stop drug pricing reform Proposition 61 after Wall Street began to query the companies about losing the election. For the first time, Proposition 61 was mentioned in an earnings call by a major drug company on October 18th. On the call, Goldman Sachs analyst Jami...
News Release
10/10/2016
CONTACT Carmen Balber & Jamie Court
Santa Monica, CA – After news broke Friday that Mylan must pay $465 million for overcharging Medicaid for the EpiPen, mothers whose children rely on the life-saving allergy drug denounced drug company greed, and called on voters to pass Proposition 61 to stop drug company price-gouging and save lives. Consumer Watchdog released an analysis...
News Release
10/4/2016
CONTACT Jamie Court & Liza Tucker
Santa Monica, CA—Consumer Watchdog today called out the Kaiser Family Foundation for holding a one-sided debate on drug price controls tomorrow that allows the opponents of Prop 61, the drug makers who raised $90 million against the effort to rein in California’s drug bills, a seat but leaves proponents out. The drug-pricing panel...
Blog Post
9/27/2016
By Jamie Court
You have to have the deepest respect for the women and men who serve our nation and put their lives on the line for Americans. That’s why it’s particularly galling when a Sacramento lobbyist profits by making money from drug companies under their name. The latest episode is in the fight over Prop 61, which reins in drug company...
Video
9/20/2016
Our Executive Director Carmen Balber speaks at a rally for #YesonProp61 in Downtown L.A.: "This issue is not going to change in Sacramento, it’s not going to change in Washington, D.C., it’s going to change because the voters take to the street and say no more, and force Pharma to lower prescription drug prices!" #...
Blog Post
5/17/2016
By Jamie Court
Los Angeles Times columnist Michael Hiltzik recently took on the "drug money" against a November ballot measure to require the state to pay the lowest price available for prescription drugs, which is the Veterans Administration prices.    Drug companies have put up $100 million against the effort by the AIDS Healthcare...
News Release
2/24/2015
CONTACT Michael Kapp & Carmen Balber
SANTA MONICA, CA: Saying the public has a right to know, Consumer Watchdog called upon Senators Mike McGuire and Jim Beall to subpoena Department of Health Care Services data on prescribing patterns of psychotropic medication by doctors to foster youth. Senator McGuire and Senator Beall are holding a joint legislative hearing today on the misuse...
Blog Post
8/17/2011
By Judy Dugan
FICO, the company that decides your credit score, is now predicting, for profit, whether you're likely to take your prescription drugs on schedule. No matter why FICO says they're doing it (insurance companies are their obvious clients) this is wrong in so many ways that it's hard to know where to start. For one thing,...